Shimamura, Akiko
Harvard Medical School,
United States
2025 Rank: 60598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1156 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60598 | 63913 |
| Total Cites | 1326 | 1542 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 46 | 46 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 310 | 322 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 985 | 1145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.35 |
| Self-Citation Percentage |
14.01%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2024 Rank: 78973
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1583 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78973 | 71536 |
| Total Cites | 1147 | 1403 |
| H-index | 14 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 8 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 37 | 39 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 279 | 307 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 859 | 1010 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
18.25%
|
|
Shimamura, Akiko
Children's Hospital Boston,
United States
2023 Rank: 84363
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1851 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84363 | 87891 |
| Total Cites | 707 | 822 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 49 | 51 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 250 | 279 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 517 | 571 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.44 |
| Self-Citation Percentage |
13.99%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2022 Rank: 57611
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1429 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57611 | 55308 |
| Total Cites | 747 | 844 |
| H-index | 14 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 10 | 11 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 63 | 67 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 279 | 311 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 552 | 589 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
11.49%
|
|
Shimamura, Akiko
Harvard Medical School,
United States
2021 Rank: 71001
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1601 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71001 | 74235 |
| Total Cites | 971 | 1093 |
| H-index | 16 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 81 | 83 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 391 | 425 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 732 | 783 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
11.16%
|
|
Shimamura, Akiko
Dana-Farber Cancer Institute,
United States
2020 Rank: 87785
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1833 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87785 | 81202 |
| Total Cites | 623 | 752 |
| H-index | 14 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 39 | 43 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 233 | 286 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 459 | 497 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.51 |
| Self-Citation Percentage |
17.15%
|
|